Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Amylyx Pharmaceuticals In...

    NASDAQ: AMLX · Real-Time Price · USD
    8.01
    -0.40 (-4.76%)
    At close: Aug 15, 2025, 3:59 PM
    8.00
    -0.12%
    After-hours: Aug 15, 2025, 04:20 PM EDT

    Amylyx Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -301.74M 49.27M -198.38M -87.93M
    Depreciation & Amortization
    		 904K 1.09M 487K 52K
    Stock-Based Compensation
    		 33.04M 37.16M 21.71M 3.14M
    Other Working Capital
    		 -57.08M -81.54M 21.58M 3.92M
    Other Non-Cash Items
    		 126.88M -9.94M -2.06M 5.23M
    Deferred Income Tax
    		 n/a n/a n/a 121K
    Change in Working Capital
    		 -45.83M -65.66M -1.64M 4.59M
    Operating Cash Flow
    		 -167.65M 11.92M -179.87M -74.8M
    Capital Expenditures
    		 -157K -1.24M -2.53M -353K
    Cash Acquisitions
    		 n/a n/a 236.46M -3M
    Purchase of Investments
    		 -231.99M -300.83M -415.87M -49.05M
    Sales Maturities Of Investments
    		 344M 394.12M 179.41M 3M
    Other Investing Acitivies
    		 -36.2M n/a -236.46M 3M
    Investing Cash Flow
    		 75.65M 92.05M -238.99M -46.41M
    Debt Repayment
    		 n/a n/a n/a 25.9M
    Common Stock Repurchased
    		 n/a -3.31M n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 348K 3.54M -658K -2.39M
    Financial Cash Flow
    		 348K 3.54M 431.79M 158.51M
    Net Cash Flow
    		 -92.08M 107.67M 12.87M 37.31M
    Free Cash Flow
    		 -167.8M 10.68M -182.4M -75.15M

    Add to Watchlist